ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000769.1|Glycopeptidolipid_1 # 3 # 518 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.690	BGC0000769.1|Glycopeptidolipid_1 	3	518	+	Loose	700	27.7202	vanS gene in vanA cluster	37.5	3002931	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GTCGAGTGCGGAGTGTGGCGAGGTGGGGCGTCGATTCTGATGCGCGCCGTGCTGTCGGCCTACGGCGACGAGAGGCGCTGCGTGTGGCTGTGCGATTCCTTCGAGGGCGTGCCGCCGCCGGACACCGCGCATTACCAGGCGGACAAGGGCATCAAGCTGCACCGCGCCGCCGGGATACTGGCCGTCCCCGAGGCGCAGGTCCGGGCGAATTTCGAGCGCTACGGCCTGCTCGACGACCGGGTCCGCTTCGTTCCCGGGTGGTTCAAGGACACCCTGCAGGATGCGCCGATCGAACGGATCGCCGTGCTGCGCCTCGACGGCGACCTGTACGAATCGACGATCCAGGCCCTGGACGCGCTCTACCCGCGGCTGTCGGCGGGCGGCATCTGCATCATCGACGACTACCACGCCATCGACGCCTGCCGGCAGGCGGTGACCGACTACCGTTCCGAACACGGCGTGACCGCGCCGATCGAGGAGATCGACGGCACCGGCGTGCTGTGGCGCAAGTCCTGA	VECGVWRGGASILMRAVLSAYGDERRCVWLCDSFEGVPPPDTAHYQADKGIKLHRAAGILAVPEAQVRANFERYGLLDDRVRFVPGWFKDTLQDAPIERIAVLRLDGDLYESTIQALDALYPRLSAGGICIIDDYHAIDACRQAVTDYRSEHGVTAPIEEIDGTGVLWRKS	MVIKLKNKKNDYSKLERKLYMYIVAIVVVAIVFVLYIRSMIRGKLGDWILSILENKYDLNHLDAMKLYQYSIRNNIDIFIYVAIVISILILCRVMLSKFAKYFDEINTGIDVLIQNEDKQIELSAEMDVMEQKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSIIGYLSLLDEAPDMPVDQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKTHIDLYYMLVQMTDEFYPQLSAHGKQAVIHAPEDLTVSGDPDKLARVFNNILKNAAAYSEDNSIIDITAGLSGDVVSIEFKNTGSIPKDKLAAIFEKFYRLDNARSSDTGGAGLGLAIAKEIIVQHGGQIYAESNDNYTTFRVELPAMPDLVDKRRS	44.53	gnl|BL_ORD_ID|1809|hsp_num:0	1907			657	753	vancomycin; teicoplanin
BGC0000769.1|Glycopeptidolipid_2 # 641 # 1921 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.686	BGC0000769.1|Glycopeptidolipid_2 	641	1921	+	Loose	600	79.7221	rgt1438	27.73	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGAAATGTGTGCTGGCCAGCTACGGGACGCGCGGGGACATCGAGCCATCCGTGGTGGTCGCCCGCGAACTGCAGCGCCGGGGCCACGACATGATCATGGCCGTGCCGCCCGACTCGGTGAGCTTCACTGAGGCGGCCGGGTTGACGGCCGTCCCCTACGGGCTGGACTCGCAGGCCTGGCTCGACGTGTACCGCAACTTCTGGACGTCGTTCTTCCGGGGGTTCTGGAAGATGGGGGAGATGCGCGGCATGTGGCGCGAGATGTGGGATCTCAGCGACCAGTGCTGGGCGCAGATGAACACCACGCTGCTGTCGCTGGCCGACGGAGCCGACCTGCTGTTCGCCGGCCAGAGCTACCAGGAGCCCGCCGCCAACGTCGCCGAGTATTACGACCTTCCGCTGGCCACCCTGCACCACGTGCCGATGCGGCCCAACGGCCAGGTCGTTTCGGTGCTGCCGGCACCGCTGGTCCGCTCGGCGATGACGGCGTTCGACTGGTTCTGCTGGCGGCTGAACAAGAAGGTCGAGGACGCTCAGCGCCGCGAGCTGGGCCTGCCCAAAGCGACCGGACCGTCGCCGCGACGGATCGCCGACCGCGGCTCGCTGGAAATCCAGGCCTACGACGAGGTCTGCTTCCCCGGCCTGGCCGAGGAATGGGCGAAATGGGATGGCCAACGGCCCTTCGTCGGCACGCTGACAATGGAGTTGACCACCGAGGCCGACGACGAGGTGATGTCCTGGATCCGCGGCGGAACGCCGCCGATCTGCTTCGGCTTCGGCAGCATGCCCGTCGAGTCGCCGGCCGACACGGTCGACATGATCGGCACGGCCTGCGCCCAGCTGGGCGAGCGCGCGCTGCTGTGCGCCGGCCCGCAAGTGACTTCAGCGGGCGTCCCGGTGCCCGATCACGTCAAGGTGGTGGGCCCGGTGAACTACGCCACCATTTTCCCGGCCTGCCGCGCGGTCGTGCACCACGGCGGCTCGGGCACCACGGCCGCGAGCCTGCGCGCCGGCGTGCCCACCTTGATCCTGTCCATGGACGCCAACCAGACCATCTGGGGCGCACAGCTCAAACGGCTGAAAGTCGGTGCCACACGGCGTTTTTCGGCAACCGACCGCGACTCGCTGGTGCAGGATCTGCGCAAGATCCTGGCCCCGGATTACGCTCGGCGCGCCCGCGAGATCGCCGCCCGGATGACCAGGCCCGCCGACAGCGTCATGAAGGCCGCCGATGTCGTGGAGGACTTCGTCCAATCCCGCAGCCGCACCGGTCGCAGCTAA	MKCVLASYGTRGDIEPSVVVARELQRRGHDMIMAVPPDSVSFTEAAGLTAVPYGLDSQAWLDVYRNFWTSFFRGFWKMGEMRGMWREMWDLSDQCWAQMNTTLLSLADGADLLFAGQSYQEPAANVAEYYDLPLATLHHVPMRPNGQVVSVLPAPLVRSAMTAFDWFCWRLNKKVEDAQRRELGLPKATGPSPRRIADRGSLEIQAYDEVCFPGLAEEWAKWDGQRPFVGTLTMELTTEADDEVMSWIRGGTPPICFGFGSMPVESPADTVDMIGTACAQLGERALLCAGPQVTSAGVPVPDHVKVVGPVNYATIFPACRAVVHHGGSGTTAASLRAGVPTLILSMDANQTIWGAQLKRLKVGATRRFSATDRDSLVQDLRKILAPDYARRAREIAARMTRPADSVMKAADVVEDFVQSRSRTGRS	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	103.65	gnl|BL_ORD_ID|116|hsp_num:0	134			0	1221	rifampin; rifaximin; rifabutin; rifapentine
BGC0000769.1|Glycopeptidolipid_3 # 2300 # 3607 # 1 # ID=1_3;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.651	BGC0000769.1|Glycopeptidolipid_3 	2300	3607	+	Loose	600	96.6709	rgt1438	28.31	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	TTGATTAAGGTAATAATCGCGATGAAATTTGCTGTGGCAAGTTATGGGACGCGTGGCGATATCGAGCCTTGCCTCGCCATTGGTCGTGAACTGATGCGCAGAGGGCATTCGGTACGCATGGCCGTCCCGCCCAATCTGGTCGATTTAGCCGAAGCCGCCGGACTGTCGGCGATCGCGTATGGGCCGGATATGCACGACTTTTGGAGCGACGAGTTCATCCGGGACTTCTTCAAAAACTTCCTGCGCGGCCCGGTCACATTGATCCGCGAAGCCTGGGAACCGGTATTGAAGAACTGGCAGGAAATGAGCTCGGCGTTGATGTCGGTGGGCGCCGGAGCTGATTTGCTGTTCACCGGCCAGCTTTACCAGGACCTGGCCATCAATGTCGCCGACTATTACGGCATCCCGATGGCCACGCTGCACTACATTCCGATGCGCCCCAACGGCCAGCTGCTGCCGCGGGTGCCGGCACCGCTGGTCCGCACCGGGATGGCCGTCTACGACTGGATGTGCTGGCGGATGAACAAGAAGGCCGAGGACAGGCAGCGCCGCGAACTCGGCCTACCGACCGCCACGGTGGCCTCACCGCGCCGGATCGCCGAGCGCGGGTCGCTGGAAATCCAGGCCTACGACGAGGTTTGCTTTCCCGGGTTGGCCGAGGAATGGGCGAAATGGGGCGGGCAGCGGCCGTTCGTGGGCTCGCTGACCATGGAGCTGCCCACCGACTTCGATGACGAGGTGTTGTCCTGGATCGGCCAGGGAACGCCGCCGATCTGCTTCGGCTTCGGCAGCATGCCGGTGGCCGAATCCCCGGCCGACACGGTCGAGATGATCGGCGCGGCATGTGCGGAACTGGGGGAGCGGGCGTTGATCTGCTCGGGCTGGAGTGACTTCAGCAATGTCCCGCACCCAGACCACGTCAAGGTGGTCGGCGTGGTCAACTACACCAAGATCTTCCCGGCCTGCCGCGCGGTCGTGCACCACGGCGGCTCGGGCACCACCGCCGCCGGCCTGCGGGCGGGAATTCCCAGCCTGATCCTGTGGACCGCCGGTGATCAGCCGCTGTGGGGGTCGCACATCAAGCGGCTGAAGGTGGGCACCTCGCGGCGGTTCTCGGCCACCACGCCCGAAACGTTGGTGGCCGACCTGCGGAAGATCCTGGCGCCCGAATACCTCACCCGCGCGCGCGAACTGTCCTCGCGGATGAGTAAGCCCGCCGAGAGCGCGGGCCGGGCGGTCGACCTGTTGGAGGAATTCGCTCGCTCGGGCCGCTGCATTCCGCGGGCCGAAGCGCAGCGAAGTCGCTGA	MIKVIIAMKFAVASYGTRGDIEPCLAIGRELMRRGHSVRMAVPPNLVDLAEAAGLSAIAYGPDMHDFWSDEFIRDFFKNFLRGPVTLIREAWEPVLKNWQEMSSALMSVGAGADLLFTGQLYQDLAINVADYYGIPMATLHYIPMRPNGQLLPRVPAPLVRTGMAVYDWMCWRMNKKAEDRQRRELGLPTATVASPRRIAERGSLEIQAYDEVCFPGLAEEWAKWGGQRPFVGSLTMELPTDFDDEVLSWIGQGTPPICFGFGSMPVAESPADTVEMIGAACAELGERALICSGWSDFSNVPHPDHVKVVGVVNYTKIFPACRAVVHHGGSGTTAAGLRAGIPSLILWTAGDQPLWGSHIKRLKVGTSRRFSATTPETLVADLRKILAPEYLTRARELSSRMSKPAESAGRAVDLLEEFARSGRCIPRAEAQRSR	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	105.84	gnl|BL_ORD_ID|116|hsp_num:0	134			0	1227	rifampin; rifaximin; rifabutin; rifapentine
BGC0000769.1|Glycopeptidolipid_4 # 3710 # 4510 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.653	BGC0000769.1|Glycopeptidolipid_4 	3710	4510	+	Loose	700	27.7202	ADC-128	35.29	3006303	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	GTGACCGATCACGACACGCGGTTTGCATACCTCGACCTGCTCCGGCGTGATCTGACCAGGTATGGCAGCGACGAGTTGGTGCCGGTCGGGTTGTACCGGCTCGGGCGCCCGCTGTTCAGCACCCGCAACTTGATGTTGGTGCGCAAGCGCCCGTTCAACAAGCAGGCCCGCGACCTGGGCCTGGACTGGCCGGCGGACGCGCTGACCATGATCGGCATGAAGCGGCTGACCAGCTTGCAGCATTGCGTGGAAACGGTTCTGGAAGAAGACGTTCCGGGTGATCTGGTCGAGTGCGGCGTGTGGCGTGGCGGGGCGTCGATCTTGATGCGTGCCGTGCTGGCGGCTTACGGCGACGAGAAGCGCTGCGTGTGGCTGTGCGATTCCTTCGCCGGAGTGCCCCCGCCGGACACCGTCAACTACAAGGCGGACAAGGGGATTAGGCTGCACCGCCACGCGCGCATCCTGGGTGTGCCGCTGGAGAACGTCAAGGCGAATTTCGAGCGCTACGGGCTGCTCGACGACCAGGTGCGTTTCGTGCCCGGCTGGTTCAAGGACACGCTGAAAGACGCCCCGATCGATCGCATCTCGGTATTGCGGCTCGACGGCGATCTCTACGAATCCACCATCCAGGCGCTCGACGCGCTGTACCCGCGACTGTCCCCCGGCGGCTTCTGCATCGTCGACGACTACCACGCCATCAAGGCGTGCGCGCAGGCCGTGACGGACTACCGCACCCAGCACGGTGTCACCGCGGAGATCGTAGAGATCGACGGCACCGGCGTGCTGTGGCGCAAGCCCTGA	MTDHDTRFAYLDLLRRDLTRYGSDELVPVGLYRLGRPLFSTRNLMLVRKRPFNKQARDLGLDWPADALTMIGMKRLTSLQHCVETVLEEDVPGDLVECGVWRGGASILMRAVLAAYGDEKRCVWLCDSFAGVPPPDTVNYKADKGIRLHRHARILGVPLENVKANFERYGLLDDQVRFVPGWFKDTLKDAPIDRISVLRLDGDLYESTIQALDALYPRLSPGGFCIVDDYHAIKACAQAVTDYRTQHGVTAEIVEIDGTGVLWRKP	MRFKKISYLILPSLFIFNTSIYAGNTSKEQDIKKVVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKSVNGNTIFELGSVSKLFTATAGGYAKTKEKISFDDTPGKYWKELKNTPIDRVNLLQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNQIGEYRQYSNPSIGLFGKVVGLSMNQPFSQVLEKTIFPSLHLKHSYVNVPKTQMQNYAFGYNQENQPIRVTPGPLDAPAYGVKSTLPDMLSFIDANLNPQKYPADIRRAIDETHKGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSIKMFHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	69.45	gnl|BL_ORD_ID|3161|hsp_num:0	4199			297	399	
BGC0000769.1|Glycopeptidolipid_5 # 4625 # 5428 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.660	BGC0000769.1|Glycopeptidolipid_5 	4625	5428	+	Loose	575	31.187	ELM-1	33.33	3006885	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ELM beta-lactamase	ATGGTTGCCGGCGTGGCTACAGGGCTGACCCCCGGCACGCGCCTGCGGATGTGGTGGGTGCGCACCGAATACTGGCTGGCACGCACGCTGCTGCCGGACGTCTACGCCAACGATGCGCTGATCACCTTCAACAACTTTCATGCATTCCTGGACGATCCCGAATTTCAGCGCGCCTACCGGCGCGGCGCCCGCTCGCTGGGCAAGGAGGACTGGTACCAGTGGCCGTGGCGGGTGCACGTGGGGCTGTGGGCGGCGGCCAGCGCCAGCCTGCTCGACGGCGACTTCGTCGAGTGCGGCGTCAGTTACGGCTTCTTGAGCAGCGCCATCATGGAGTACCTGGACTGGGACCGGCTGGGCAAGACGTTCTACCTGCTGGACACCTTCGCCGGCATCGACCCGCGGTTCGTCACCGACAACGAACGCGCGGCCGGGGCGCTGGAGATCAGCAAGGGGCATCTGCGCAACGGCATGTATGCCAACGGAGTCGACGGTGTCCGCGCCAATTTCGCGGAATGGAAAAACCACCGCATCATCGTGGGCGCGGTCCCCGAGACCCTCGATCAGGTCGATGCGCCCTCGGTGGCCTATTTGCACATCGACATGAACTGTGCTCCGCCCGAAGTCGCCGCGCTGCGCTTCTTCTGGCCGCGCCTCACTCTCGGCGCCTTCGTGCTGCTCGACGACTATGCGAACCGGGGACGCGACGAACAGCGCCGCGCCATGGACGAGGTCGCCGCCGAATTCGGTGTGAAGATCTGCACATTGCCCACCGGGCAGGGCCTGCTCATCAAGCCGGCCCGCTGA	MVAGVATGLTPGTRLRMWWVRTEYWLARTLLPDVYANDALITFNNFHAFLDDPEFQRAYRRGARSLGKEDWYQWPWRVHVGLWAAASASLLDGDFVECGVSYGFLSSAIMEYLDWDRLGKTFYLLDTFAGIDPRFVTDNERAAGALEISKGHLRNGMYANGVDGVRANFAEWKNHRIIVGAVPETLDQVDAPSVAYLHIDMNCAPPEVAALRFFWPRLTLGAFVLLDDYANRGRDEQRRAMDEVAAEFGVKICTLPTGQGLLIKPAR	MPMEQALFVRIARALAASLITLSAVAFAQEPKVDIPADQQAFVDICKPWDEWDKPAPPFEIYRDTYYVGTCGIAAILITDEEGHILIDSGTEAGADVVMANVAALGFDLKDVRYLLYSHEHFDHVGGMAKLQRATGALVVASKAAEPVLTSGEDSLADPQHGMHEPFEGVAVGRIMAAGDILELGGTTIRAIETPGHTPGAMSWWWQECKERCENIVYADSLSPISRDDYRFGDHPEYVAAYRAGLVALGREDCTVLLTPHPSHSRMIRRMQEGDLIENRQGTRPCARYAGQKLLDLETRLSNETLSEEDRAQ	85.30	gnl|BL_ORD_ID|3530|hsp_num:0	4599			585	759	
BGC0000769.1|Glycopeptidolipid_6 # 5502 # 6281 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.679	BGC0000769.1|Glycopeptidolipid_6 	5502	6281	+	Loose	710	25.0238	cmeA	23.85	3000783	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; fusidane antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCTTTGGCAATGATCACCGGCGCGTCGAGCGGAATCGGACTCGAACTCGCGGAACTGTTCGCCCAGCGCGGTTATGACCTGGTGGTGGCCGCCGAAAACGACGGCATCTACCCGGCGTCGGACAGCTTGTCCCGCTGGGGTGTCGACGTGCGGCCGGTACAGGTCGATCTGCGCACTCCCGAGGGCGTCGAGAAGCTCTATCGTGAGGCCACCGAGGGTGGTCGCGGGTTGGACGCGGTCGCGCTGAACGCGGGCGTGGGCGGCGGGGGCAGTTTCGTCGAGGGCGAGCTGGCGCACGATCTGTCCATCATCGACCTGAACGTGCGCTCGACCGTGCACCTGGCCAAGCTGGTGCTGCGCAACATGACCCGGCGCAACACCGGCAAGGTGCTGTTCACGTCGTCGCTGGCGTCGATGGCGCCCGGGCCGTTCGAGGCGGTGTATCACGCCTCCAAGTCGTTCGTTCAGTCGTTCGCCGGGGCGCTGCGGGACGAATTGCGCGATACCGGAATCACCGTCACCGCGCTGATGCCGGGCACCATCGAGACCAACTTCTTCAGCCGTGCGGGCATGGATCAGACCCGGGCGGGCCAGAAGCCGAAGGACGACCCGGCCGAGGTGGCCAGGCAGGGGTTCGAGGCGATGATGCGGGGCCACCGCAAGGTCGTCGGGGGCTCGCTGACCACCAAGACGGTCGGGGTGGCGCTGCGGTTCCTCCCCGACTCGTGGAAAGCGGCTGCCAGCCGGGCGAATTCCACACCGGCGGGCCGGCGGTAA	MALAMITGASSGIGLELAELFAQRGYDLVVAAENDGIYPASDSLSRWGVDVRPVQVDLRTPEGVEKLYREATEGGRGLDAVALNAGVGGGGSFVEGELAHDLSIIDLNVRSTVHLAKLVLRNMTRRNTGKVLFTSSLASMAPGPFEAVYHASKSFVQSFAGALRDELRDTGITVTALMPGTIETNFFSRAGMDQTRAGQKPKDDPAEVARQGFEAMMRGHRKVVGGSLTTKTVGVALRFLPDSWKAAASRANSTPAGRR	MKLFQKNTILVLGVVFLLTACSKEEAPKIQMPPQPVTTMSAKSEDLPLNFTYPAKLVSDYDVIIKPQVSGVIVNKLFKAGDKVKRGQTLFIIEQAKFKASVDSAYGQALMAKATFENASKDFNRSEALFSKNAISQKEYDSSLATFNNAKASLASARAQLANARIDLDHTEIKAPFDGTIGDALVNIGDYVSTSTTELVRVTNLNPIYADFFISDTDKLNLVRNTQSGKWDLDSIHANLNLNGETVQGKLYFIDSVIDANSGTVKAKAVFDNNNSTLLPGAFATITSEGFIQKNGFKVPQIAIKQDQNDVYVLLVKNGKVEKSSVHISYQNNEYAIIDKGLQNGDKIILDNFKKIQVGSEVKEIGAQ	70.57	gnl|BL_ORD_ID|1089|hsp_num:0	1181			606	876	erythromycin; cefotaxime; fusidic acid
BGC0000769.1|Glycopeptidolipid_7 # 6288 # 7544 # -1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.678	BGC0000769.1|Glycopeptidolipid_7 	6288	7544	-	Loose	600	105.145	rgt1438	29.21	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	GTGAGATTTGCCCTGGCCAGTTACGGAACTCGCGGCGATATCGAGCCGTCCGCCGCGGTGGGCCGTGAGCTGCTGCGCCGGGGCCACGACGTTCGCCTGGCGGTCCCCCCCGAGCTGGTCGGCTTCGTCGAGTCGACCGGGCTGGCGGCGGTGCCCTACGGCCCCAAGGTGCAGGAGTTCCTCGACGAGGAATTCCTGCGCAACATGTGGCGAAACTTCTTCCGCAACCCGATCAGGCTGGTCCTCAAGGTGTGGGATCCGATCATCAAGTACTGGGCCGAGGCGAGTGCCACGCTCAAATCGGTGGCCGAGGGGGCGGACCTGCTGAGCACCGGCCTGAACTTCGAACAGGCCGCCGCCAATGTGGCTGAGTACTACGACATTCCGTTGGCATCGCTGCACCACTTCCCGATGCGCGCCAACGGGCAGCTGGTCCCCAACATGCCGTCACCGTTGGTGCGCTCGACGATGACGGCCATCGAGTGGCTGTTCTGGCGTTCGACGAAGAAGGTCGACAACGCGCAGCGCCGCCAACTCGGGCTGCCCAAGGCGACCCGACGTTCGCAGCGACGGATCGCCGAGCGCGGCTGGCTGGAAATCCAGGCCTATGACGAGGTGTGTTTCCCCGGCCTGGCCGCCGAATGGGCGCACTGGGGCGACCGGCGCCCGTTCGTCGGCGCGCTGACGATGGAGCTGGCCACGGAATCCGACGACGACGTCGCGTCGTGGATCGCCGCGGGAACCCCGCCGATTTGCTTCGGCTCCGGAAGCATTCCGCTCGAATCTCCCACTGCCACAGTCGAAATGATCGGCGCGGCCTGTGCGCGGCTGGGAGAGCGGGCGCTGATCTGCTTCGGCGGCACCGACGTGCGCGGAGTACCGCGTTTCGACCACGTCAAGGTGGTCGGGCCGGTGAACTACGCGTCGGTCTTCCCAGCCTGCCGGGCCGTCGTTCACCACGGCGGCTCGGGCACCACCGCGGCGAGCCTGCGAGCGGGCATCCCGACCCTGGCCCTGTGGAGCTCGGCCGATCAACCCTATTGGGCAGCGCAGATCAAACGCCTGAAAGTGGGTACGGCCCGGCGTTTTTCGGCCACCACGTCCGAGACCCTGGTGGCCGACCTGCGCACCATCCTGGCGCCCGACTATGCGACCAGGGCGCGCGACTTGGCCGCCCGGATGACCAAGCCCGCCGAAAGCATCGAGACCACCGCCGACCTCCTGGAAGCCGCCGCCCGCCGGAAAACCTTGGGCTGA	MRFALASYGTRGDIEPSAAVGRELLRRGHDVRLAVPPELVGFVESTGLAAVPYGPKVQEFLDEEFLRNMWRNFFRNPIRLVLKVWDPIIKYWAEASATLKSVAEGADLLSTGLNFEQAAANVAEYYDIPLASLHHFPMRANGQLVPNMPSPLVRSTMTAIEWLFWRSTKKVDNAQRRQLGLPKATRRSQRRIAERGWLEIQAYDEVCFPGLAAEWAHWGDRRPFVGALTMELATESDDDVASWIAAGTPPICFGSGSIPLESPTATVEMIGAACARLGERALICFGGTDVRGVPRFDHVKVVGPVNYASVFPACRAVVHHGGSGTTAASLRAGIPTLALWSSADQPYWAAQIKRLKVGTARRFSATTSETLVADLRTILAPDYATRARDLAARMTKPAESIETTADLLEAAARRKTLG	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	101.70	gnl|BL_ORD_ID|116|hsp_num:0	134			0	1179	rifampin; rifaximin; rifabutin; rifapentine
BGC0000769.1|Glycopeptidolipid_8 # 7677 # 8354 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.655	BGC0000769.1|Glycopeptidolipid_8 	7677	8354	-	Loose	990	26.1794	qacA	59.09	3003046	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGATATCGCTGCGAAAACCATTGGAGCTTAAGTGGATCAAACGCGGCGGGCGCATCGCGAGCCTTCCGCGCCGGTTGCCGCCGGCGGCGCGCAAATCCGGGATCGAATCATCGGCACGGGGAACCGACAAGCTCGGTGCCCTGCCCCTGGCCGAAGCGTATGGTCAGCCCGGCGCGACCCGGAAACCCAAACAGGTCCGGGCGGCCTCGTGGCAGGGCGACTTGTACGCCTACCTGGTGCGCTGGCGCGACCCCGGGATCGTCGTCGAGTTCGGGTCGGCGTTCGGGGTGTCCGGGATGTACCTGTCGTCGGAGCTGCGGCGGGGCTGGCTGTATTCGTTCGAGATCAACCCCTCCTGGGCCGACATCGCCGAACGGAACATCAAATCCGTCACCGATCGCTGCACCCTGACGCGGGGCGCCTTCGAGGACCATGTTGACGACATCCCCGCACCGATCGACATGGCGTTGGTCGACGGAATCCACAGCTACGACTTCGTCGCGCGACAGTGGCAACTGCTGAAGCCCCGAATGGCGCCGGGTGGGTGGGTGCTGTTCGATGACATCGACTTCAACCCCGGGATGGGCAACGCATGGCAGGACATCTGCGCCGAGCCGCACGTGGTGGGGGCCGTCGAAGTGTCCAAACGGCTGGGCCTCATCGAATTGGCGCCCTAG	MISLRKPLELKWIKRGGRIASLPRRLPPAARKSGIESSARGTDKLGALPLAEAYGQPGATRKPKQVRAASWQGDLYAYLVRWRDPGIVVEFGSAFGVSGMYLSSELRRGWLYSFEINPSWADIAERNIKSVTDRCTLTRGAFEDHVDDIPAPIDMALVDGIHSYDFVARQWQLLKPRMAPGGWVLFDDIDFNPGMGNAWQDICAEPHVVGAVEVSKRLGLIELAP	MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELDPSGTQQLWIVDIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIAGALIMPTTLSMIRVIFENPKERATALAVWSIASSIGAVFGPIIGGALLEQFSWHSAFLINVPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIPWVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMASVLLLASQWLQVVEELSPFKAGLYLLPMAIGDMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFFGHPLSYSTMALALILVGAGMASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAVLGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFNDAFVATALVGGIIMIIISIVVYLLIPKSLDITKQK	43.77	gnl|BL_ORD_ID|339|hsp_num:0	372			1347	1413	
BGC0000769.1|Glycopeptidolipid_9 # 8351 # 9400 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.673	BGC0000769.1|Glycopeptidolipid_9 	8351	9400	-	Loose	500	26.9498	APH(6)-Id	40.54	3002660	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	ATGGGTGTCACCGGCGAGCCGACCGTGGCGTACCTGGGCTGGCATGGGCTGGGCAACCTTGGCGACGACGCGATCTACGACGCGGTGCAGAGCCAATTGCGTGGCGCCACCTTTCTCGATTTGCCGCGCCTCCCACACCAGCTGATCTATGCAACCGCCACGGCGGCGATGGGTTTGAACCGGTCGCTGCGGCGCAGCAGGCAGCTCGTGGGTGGCGGCACGCTGGTCGGCAGGAGCCAGTGGCGGCTCTTGGTCAATCGGGGGTTGGCGCTCACCAAAGACAACGGAAGTTACGCGATCGGCGTCGGCGTGGAGGACCCGGTATTCGGCGGCCGCAACAGCGGCTCGGGCAACGGCGAGCTGAAACGTTGGGCACCGATACTTTCCAAATTTCGCACCGTGTCGGTGCGCGGGCCACGCAGCGCCGAACTGCTCGCCGACATCGGGCTGGACGTCGAGGTATCCGGCGATCCGGCGCTGCTACTCCCCCGGCCCGACGTCACCGCCGAAGACGACCTGATCGGTGTGAATCTCGGCTTCGGCGACGACCTTTGGGGACACGACCCGAAGCGGCTAGCGGACGAGGTCGCCGGCGCCGTCAAGCAACTGGCATCGCACGGCTACCGCTTCGTCGGCATTCTGATGAATCCGGCAGACCGACGCTGGACCGAGACCGCGCTGAGAGACGTTCCGCACGCACCGATCGTGCTTCCGGCCGATCCCGGCGCCGCGGCGCGGGAACTGGCCCGTTGTTCGGCCGCCATCGTCACCCGCCTGCACGCCAGCGTTCTGGCGTCGCTGTCCGATACACCCGTCGTTTCGCTTGAATACCAACCAAAATGCCGCGACTTCGCGCTCGCCATCGACGACGAGCCGGCACTGATTCGCACCGATCAGGTGCGCGGCGCCACCGTCGCCGACCGGGTGCTGGACACGATCGCGAACGCGTCGAACATCCGCGCCAGGAAGCGCAGCGCCGTCGCGCGGCTGAAAACGCGGCTGGGGGTCGAGTACGCGGATTTGGCCCGCGAGTTGGGGCTCGCCTCGTGA	MGVTGEPTVAYLGWHGLGNLGDDAIYDAVQSQLRGATFLDLPRLPHQLIYATATAAMGLNRSLRRSRQLVGGGTLVGRSQWRLLVNRGLALTKDNGSYAIGVGVEDPVFGGRNSGSGNGELKRWAPILSKFRTVSVRGPRSAELLADIGLDVEVSGDPALLLPRPDVTAEDDLIGVNLGFGDDLWGHDPKRLADEVAGAVKQLASHGYRFVGILMNPADRRWTETALRDVPHAPIVLPADPGAAARELARCSAAIVTRLHASVLASLSDTPVVSLEYQPKCRDFALAIDDEPALIRTDQVRGATVADRVLDTIANASNIRARKRSAVARLKTRLGVEYADLARELGLAS	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEQEQRDLAIAAAIKQVRQTSY	125.54	gnl|BL_ORD_ID|950|hsp_num:0	1031			399	501	streptomycin
BGC0000769.1|Glycopeptidolipid_10 # 9403 # 10470 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.654	BGC0000769.1|Glycopeptidolipid_10 	9403	10470	-	Loose	550	33.8834	PmrF	24.37	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACCGCCACAACCAGGGCAGCGGACGCACCCAAGGTCAGCGTGGTGTCGACCACCCACAACCAGCAGGCCTATGTCCGCGACACGTTGGACGGCTTCCTCGCCCAGCGGGTCGACTTTCCGATGGAGGTCATCGTCGCCGACGATGCCTCAACCGATGCCACACCCCGAATCATCCAGGACTACGCCGACCGCCATCCGAACCTCTTCCGGCCCATCCTGCGGTCGAGAAACGTCGGCCTCAACGCCAACCTCACCGGTGCCCTGTCCGCCGCGCGTGGCGAGTACATCGCGCTGTGCGAGGGCGACGACTTCTGGGTCGACCCGTTGAAACTGGCCAAGCAAGTGGCGTTGCTGGACGAAGATCCCGACACCACGGTGTGTTTCCACCCGGTGCAGGTGGTCTGGACCCACGAGTGCGCGGAGGACGAGAAACTCGTCCACACCCTGTATCGCAAGTTCGAAGAGATCTTCCTGCCCAAGTTTCCGCCGCCCTTTCGGGCGGGTGACCTCAGCTTCGAGACGCTGATCTCGCGCAACTTCATCCAGACCAACTCGGTGATGTACCGGCGCCTCCCCCGCTACGACGACATCCCGGCCGATGTCATGCCCCTGGACTGGTACCTGCACGTCCGGCATGCCGCCGAAGGCGCCATCGCCATGCTGCCGGAGACGATGGCGGTCTATCGCCGCCACCCGCGCGGCATGTGGTACAAGTCGATCACCGATCCGGCCACCTTCTGGCGGATGCAGGGTCCCGGGCATGCGGCGACATTGGACGCCATGCTCGACGTCGTCTCCGGCGACCCGGTGCACGAATCCATCGTGGCCAAAAACGCCGACTGGGTGCTGGGGGCGATCGCCAAGCAGGTCCCGGACCCCGAGGGCCAGGAAGTCCTGACGCAGACCACCGCCAAGTACCCGCGGATCGCCGCGCTGGCGCTGCGCAACCGCTGCACCAAGACGCTCGGCGGACGGGTGAAACGGTTGCGGCGCAAGCTTTCTCGCAATGCCCCTGCACCGAACAGCGATGCCGAGCGCCGAATCGACGAGCCACTGAGCGCCTGA	MTATTRAADAPKVSVVSTTHNQQAYVRDTLDGFLAQRVDFPMEVIVADDASTDATPRIIQDYADRHPNLFRPILRSRNVGLNANLTGALSAARGEYIALCEGDDFWVDPLKLAKQVALLDEDPDTTVCFHPVQVVWTHECAEDEKLVHTLYRKFEEIFLPKFPPPFRAGDLSFETLISRNFIQTNSVMYRRLPRYDDIPADVMPLDWYLHVRHAAEGAIAMLPETMAVYRRHPRGMWYKSITDPATFWRMQGPGHAATLDAMLDVVSGDPVHESIVAKNADWVLGAIAKQVPDPEGQEVLTQTTAKYPRIAALALRNRCTKTLGGRVKRLRRKLSRNAPAPNSDAERRIDEPLSA	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	110.25	gnl|BL_ORD_ID|1937|hsp_num:0	2014			24	372	polymyxin B
BGC0000769.1|Glycopeptidolipid_12 # 10772 # 11056 # -1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.646	BGC0000769.1|Glycopeptidolipid_12 	10772	11056	-	Loose	600	41.9726	rgt1438	36.76	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	GTGCCAGGTTCGGGTACCACGGCGGCAGGGCTGCGCGCCGGAGTTCCCACCCTGAGCCTCTGGAGTCTGAGCGACCAAAAGATCTGGGCCAACCAGGTCCAACGACTGAAAGTTGGCTTGGCGCGGCACTTCCCGAGCGCCACGCAGGATTCGTTGGTCACCGACCTGCGTCAGATCCTGAGCCCCGAGTACGCCATTCGCGCCCGCGCGATAGCCGCGCGTATGACCAAGCCTGCCGAGAGCGTCGCCACGACCGCCAACTTGCTGGAGAAATTTGCCGCGTGA	MPGSGTTAAGLRAGVPTLSLWSLSDQKIWANQVQRLKVGLARHFPSATQDSLVTDLRQILSPEYAIRARAIAARMTKPAESVATTANLLEKFAA	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	22.87	gnl|BL_ORD_ID|116|hsp_num:0	134			978	1182	rifampin; rifaximin; rifabutin; rifapentine
BGC0000769.1|Glycopeptidolipid_13 # 11137 # 12243 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.548	BGC0000769.1|Glycopeptidolipid_13 	11137	12243	-	Loose	555	28.8758	GOB-15	23.0	3004807	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	GOB beta-lactamase	ATGACCATATCAAACTTTAAGCAGCTGGCGGACAACGCCAAAATAGCCATCGCCGAGGCCCACATCAGCAGCCTCCGATACCTTCATAAGCGCCGACTGCGGAGAAACGAACTGGCCGTAGCCCACGGTGAGAGCAGGATCTCCGATGACCTTATCGACCGGATCTCGCGTTGGTATTCGTCTGGGGCTACGGAAAACCTCGGTGATTCGATGTGGGTAGGTATCAACCAACAGAAGCGGGACGTTCACGAGGCTCTGCTTGTCGGTGGTGAAGCCTTAAGAAACATACTACTTGATCCTGGAAGAACCAACTTCTTCCTAGGCTTCGACAGCCTTTTTAAAGATCGGGTTAAAGGTGCTCAGTTATCTTCGAATAGGCAGCGCGAATACCTCATGCGTCAGCTGATCGGGCTGGCGGAGTCCATCGGAACTTTCCGCCTGTACCATCCTGAATGCGGGCCGAAAGCAGAGTTTCCACCGACCGATGCCGACGAAATTCTTGACGGCATCGAACAACAAATCGGGATTACAGTTGATTTCCCAAATCCTTTTCCCGACGAGTTAGGTTTGAAAACGCGGCGCGGGATCGCGGCATACCGTGCCATTCATGCTGTCTACCAAGCGTGGCAGCTCTGCAGCTTGTCTCGAATTTGGGGGAACCGTATTCTCGAAATCGGCGCTGGAATGGGACGCACCGCTTACTATGCCTCCAAGATGGGATTGTGCTCCTACACGATCGTCGATATCCCTATGACATCCGCAGCGCAAGCAGCGTTTCTTGGGCAAGCCCTCGGTCCGGAGCGTGTGAGGTTGCCCGGTGAGGGGAACGACGACCGGGCCGTGCGATTGTTGAATCCCGGAAATCTGAGCGACGTAGGTCCGGTGGATATCGTGCTTAACGCCGATAGCTTGACCGAGATGGACAAGGAAGTCGCGCAAGCCTACGCGGATTACGTCGCAGCGAACGCAACCGTGTTCCTATCAATCAACCACGAGGCGAACCAGCACCGAGTGCGCGACCTGAAGTTCGATGGAATGGTGTGCGTATCCCGAAGCCCACACTGGATGCGCACCGGATATGTTGAGGAGCTGTACGTCAGAGTCTGA	MTISNFKQLADNAKIAIAEAHISSLRYLHKRRLRRNELAVAHGESRISDDLIDRISRWYSSGATENLGDSMWVGINQQKRDVHEALLVGGEALRNILLDPGRTNFFLGFDSLFKDRVKGAQLSSNRQREYLMRQLIGLAESIGTFRLYHPECGPKAEFPPTDADEILDGIEQQIGITVDFPNPFPDELGLKTRRGIAAYRAIHAVYQAWQLCSLSRIWGNRILEIGAGMGRTAYYASKMGLCSYTIVDIPMTSAAQAAFLGQALGPERVRLPGEGNDDRAVRLLNPGNLSDVGPVDIVLNADSLTEMDKEVAQAYADYVAANATVFLSINHEANQHRVRDLKFDGMVCVSRSPHWMRTGYVEELYVRV	MRNFATLFFLSVCLNLNLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAEPLPIIKGNIQKLGFNYKDIKILLLTQAHYDHTGALQDFKTETGAKFYTDKADADVLKTGGKSDYELGKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKGSCSFIFDTKDEKRKYRVLIANMPSIIVDKKFSEVTAYPNIQSDYAYTFGAMKKLDFDLWVASHASQFDLHEKRKEGDPYNPQLFMDKQNYFQSLNNLEKSYLDKIKKDSQDK	126.03	gnl|BL_ORD_ID|2518|hsp_num:0	3601			564	858	
BGC0000769.1|Glycopeptidolipid_14 # 12387 # 13361 # -1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.522	BGC0000769.1|Glycopeptidolipid_14 	12387	13361	-	Loose	500	26.5646	OXA-513	28.42	3005743	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGACAACGACGCCACCAGTCATCTTCATCATCTTCAACAGGACGGACACTGCTAGCCGCGCCTTCGAAATGATCAGAGCAGCCAAGCCAGAGAAGCTCCTTGTGATTGCCGACGGCCCCCGCCCGCAGGAGCCCGGCGAGGCTGAGAAGTGCGCGGCCACACGAGCGATCATCGACCAGGTGGATTGGGACTGCGAAGTCCATAGGAACTTCTCCGAGACGAATCTCGGGATCCGCCGGCGGGTTTCGTCCGGTATAAACTGGGCCTTCGAGCTCGTCGACCGCGCCATAATACTTGAGCACGACTGCGTGGCCTCTACATCCTTTTTCCCTTACTGCGCCGAACTGCTTGATCACTACGAGAGCGACGAACGAGTCATGATGATCTCGGGGCAAAATCATCTCTTCGGACATGCGTCGACAACAGATAGCTACTACTTCTCCCGGTACCCACATGTGATGTGGGGATGGGCAACTTGGAGGCGGGCCTGGTCAATGTATGACGTCGACATGACCCACTGGCCTGAAATTAGAGCCAGGAAACTATTCGACCAGTATTTCTCGACACGCCGAGAACGCTACTATTGGGAGTCGATCTTCCAGTATGCCGTTTATGAAGGCAATGTCGATACTTGGGATTACCAATGGTTTTATAGCATGTGGGCGAATTCGGGCTTATGCATAACTCCCGCCAGGAACTTAGTGCGTAATATCGGCCTAGATGCCGAAGCGACCCATACTAATACTAAGTATGACAAGATCTATTCATTACTGAAAGCTGAGGAACTAAGTCTGCCACTTACCCATCCCGAAACCGTCAAAACCAGCCATGATAAAGACGAGCTCGAGGCGAAGCTGCGGTTTGCATACCATACCAAAGGATTATTAGGAGCATATTTCAGGTACTTGGCACTCAAAATACTGGTAAGCAGGGCCATTAGGCAGCTAAAGAAACCGGTCATTGGGTCGCCATAG	MTTTPPVIFIIFNRTDTASRAFEMIRAAKPEKLLVIADGPRPQEPGEAEKCAATRAIIDQVDWDCEVHRNFSETNLGIRRRVSSGINWAFELVDRAIILEHDCVASTSFFPYCAELLDHYESDERVMMISGQNHLFGHASTTDSYYFSRYPHVMWGWATWRRAWSMYDVDMTHWPEIRARKLFDQYFSTRRERYYWESIFQYAVYEGNVDTWDYQWFYSMWANSGLCITPARNLVRNIGLDAEATHTNTKYDKIYSLLKAEELSLPLTHPETVKTSHDKDELEAKLRFAYHTKGLLGAYFRYLALKILVSRAIRQLKKPVIGSP	MTVRRFSCALGAALSLSALAGVPARAAVLCTVVADAADGRIVFQQGTQAACAERYTPASTFKLPIALMGADAGILQGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYASAFQYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLPLKPAAYDLAETLFDAGEAGGWRLYGKTGTGSPGSNGVYTPDNAYGWFVGWARKDGRQLVFARLLQDEKATKPNAGLRARDDLMRDWPAMADAPRQ	117.82	gnl|BL_ORD_ID|3778|hsp_num:0	4848			252	507	cloxacillin; oxacillin; cefalotin
BGC0000769.1|Glycopeptidolipid_15 # 13306 # 13464 # -1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.528	BGC0000769.1|Glycopeptidolipid_15 	13306	13464	-	Loose	450	21.1718	SPM-1	29.41	3003793	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SPM beta-lactamase	GTGGCGGCGTCGATATGGTCAACAGTCTTTTATGAACTAGCCTTCGTATGCGAAACCACCCTGGATCGGTTGATTCCCGCAGAGTCGTGGCAAGGACAGGACTGTGACAACGACGCCACCAGTCATCTTCATCATCTTCAACAGGACGGACACTGCTAG	MAASIWSTVFYELAFVCETTLDRLIPAESWQGQDCDNDATSHLHHLQQDGHC	MNSPKSRALLGFMGAFCLLLVAGAPLSAKSSDHVDLPYNLTATKIDSDVFVVTDRDFYSSNVLVAKMLDGTVVIVSSPFENLGTQTLMDWVAKTMKPKKVVAINTHFHLDGTGGNEIYKKMGAETWSSDLTKQLRLEENKKDRIKAAEFYKNEDLKRRILSSHPVPADNVFDLKQGKVFSFSNELVEVSFPGPAHSPDNVVVYFPKKKLLFGGCMIKPKELGYLGDANVKAWPDSARRLKKFDAKIVIPGHGEWGGPEMVNKTIKVAEKAVGEMRL	18.84	gnl|BL_ORD_ID|2076|hsp_num:0	2298			360	462	
BGC0000769.1|Glycopeptidolipid_16 # 13492 # 13620 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.535	BGC0000769.1|Glycopeptidolipid_16 	13492	13620	+	Loose	500	20.4014	CARB-54	33.33	3005588	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CARB beta-lactamase	GTGTTTGTTGTGCCTCGGGTTTGTCTTGATCAGGAGATCGATATTTCGTCATGGTGCGTAGTGGTGAAGGTTGTCGCAGTGCAGGTCGGGTCCAACGTTGTCACGTCATTGACGTGGATGGCCCCGTAG	MFVVPRVCLDQEIDISSWCVVVKVVAVQVGSNVVTSLTWMAP	MNVRQHKASFFSVVITFLCLTLSLNANATDSVLEAVTNAETELGARIGLAAHDLETGKRWEHKSNERFPLSSTFKTLACANVLQRVDLGKERIDRVVRFSESNLVTYSPVTEKHVGKKGMSLAELCQATLSTSDNSAANFILQAIGGPKALTKFLRSIGDDTTRLDRWEPELNEAVPGDKRDTTTPIAMVTTLEKLLIDETLSIKSRQQLESWLKGNEVGDALFRKGVPSDWIVADRTGAGGYGSRAITAVMWPPNRKPIVAALYITETDASFEERNAVIAKIGEQIAKTVLMENSRN	14.09	gnl|BL_ORD_ID|3369|hsp_num:0	4438			687	759	
BGC0000769.1|Glycopeptidolipid_18 # 14042 # 15064 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.607	BGC0000769.1|Glycopeptidolipid_18 	14042	15064	+	Loose	1900	28.8758	acrB	26.37	3000216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAAGCGAGCACTCATAACCGGCATCACGGGCCAGGACGGTTCCTACCTCGCCGAGTTGTTGTTGAGCAAGGGGTATGAAGTCCACGGGCTCATCCGACGGGCATCGACGTTCAACACGACACGGATCGACCACCTCTACGTTGACCCGCACCAACAGGGCGCCCGGCTGTTCTTGCATTATGGCGATCTCACCGACGGGACTCGCCTGGTCACCTTGCTGAGCACGATCGATCCTGACGAAGTTTATAACCTCGCGGCGCAGTCCCACGTGCGCGTCAGCTTCGACGAACCCGTATACACGGCAGATACGACTGGGATGGGATCGATCCGGCTGCTCGAAGCGGTCCGGCTTTCCCGAGTGGAATGCCGCTTCTACCAAGCATCGTCGTCGGAGATGTTCGGCGCTTCGCCGCCGCCACAGAACGAGCTAACGCCGTTCTATCCGCGCTCTCCCTACGGTGCGGCGAAGGTTTACTCGTATTGGGTGACTCGCAACTACCGGGAAGCATACGGAATGTTTGCCGTCAACGGGATCTTGTTCAACCATGAATCACCGAGGCGTGGTGAAACATTCGTCACCCGGAAGATCACGCGCGCCGTCGCCCGGATCAAAGCCGGCGTCCAGTCAGATGTCTACCTGGGCAATCTCGACGCAGTCCGCGACTGGGGGTATGCGCCCGAATATGTGGAAGGGATGTGGCGGATGCTGCAGGCACCTGAGCCCGACGATTTCGTTTTGGCCACGGGGCGTGGTTACACAGTGCGCGAGTTCGCGCAGACCGCCTTCGAGCGCGCAGGGCTTGACTGGGAGAGACACGTCAAATTTGACGACCGTTACCTGCGGCCTACAGAGGTGGATTCGCTGATCGGCGATGCATCCAAAGCCGCCCGTGACCTCGGGTGGAAGGCCGCCGTGCACACCGGCGAACTGGCCCGAATCATGGTGGACGCCGACATTGCCGCGTTGGAATGCGACGGCAGACCATGGATTGACCGGCCGAACTTGCCTGCATGGAGCTGA	MKRALITGITGQDGSYLAELLLSKGYEVHGLIRRASTFNTTRIDHLYVDPHQQGARLFLHYGDLTDGTRLVTLLSTIDPDEVYNLAAQSHVRVSFDEPVYTADTTGMGSIRLLEAVRLSRVECRFYQASSSEMFGASPPPQNELTPFYPRSPYGAAKVYSYWVTRNYREAYGMFAVNGILFNHESPRRGETFVTRKITRAVARIKAGVQSDVYLGNLDAVRDWGYAPEYVEGMWRMLQAPEPDDFVLATGRGYTVREFAQTAFERAGLDWERHVKFDDRYLRPTEVDSLIGDASKAARDLGWKAAVHTGELARIMVDADIAALECDGRPWIDRPNLPAWS	MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH	32.41	gnl|BL_ORD_ID|1011|hsp_num:0	1104			1776	2040	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000769.1|Glycopeptidolipid_20 # 16173 # 16484 # 1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.519	BGC0000769.1|Glycopeptidolipid_20 	16173	16484	+	Loose	300	26.9498	Erm(37)	43.33	3000392	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGATACACGTGCATTTTCTGGAACAAGTCCGTATGATCGCCCGCAATATTCCTACCGAAGCGTTGCGATATTTATCGGAACGACACTGGAAACGCCACTTCGTCAAGCAATTAGCGGCTCATCAAGTCAATGTCGTTTTTGACGTAGGCGCCAACACAGGGCAATACACCGCAGGCCTGCGTAAAGCCGGATACAAGGGGCGGATCATCTCGTTCGAGCCTTTATCGCAGCCTTTTTCCAGGCTGGAGAATCGGGCAGCAAAAGATGCACTCTGGGACTGCAGTCGCTATGCGATCCAGTGCTGGAAGTAG	MIHVHFLEQVRMIARNIPTEALRYLSERHWKRHFVKQLAAHQVNVVFDVGANTGQYTAGLRKAGYKGRIISFEPLSQPFSRLENRAAKDALWDCSRYAIQCWK	MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAVELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLVAADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR	57.54	gnl|BL_ORD_ID|421|hsp_num:0	468			99	183	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000769.1|Glycopeptidolipid_21 # 16460 # 16639 # -1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.706	BGC0000769.1|Glycopeptidolipid_21 	16460	16639	-	Loose	1000	24.2534	MCR-5.4	41.38	3007281	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	GTGCCGCTGGTGACCCAGGCCCGCGACTGGCAGCACGGCGTGTTCATGGGCGCTACCATGGGCAGCGAGCAGACCGCCGCCGCCGAGGGCAAGGTCGGCACGGTGCGCCGCGACCCGATGGCCATGCTGCCGTTCCTGGGCTACCACGTCGGCGACTACTTCCAGCACTGGATCGCATAG	MPLVTQARDWQHGVFMGATMGSEQTAAAEGKVGTVRRDPMAMLPFLGYHVGDYFQHWIA	MRLSAFITFLKMRPQVRTEFLTLFISLVFTLLCNGVFWNALLAGRDSLTSGTWLMLLCTGLLITGLQWLLLLLVATRWSVKPLLILLAVMTPAAVYFMRNYGVYFDKAMLRNLMETDVREASELLQWRMLPYLLVAAVSVWWIARVRVLRTGWKQAVMMRSACLAGALAMISMGLWPVMDVLIPTLRENKPLRYLITPANYVISGIRVLTEQASSSADEAREVVAADAHRGPQEQGRRPRALVLVVGETVRAANWGLSGYERQTTPELAARDVINFSDVTSCGTDTATSLPCMFSLNGRRDYDERQIRRRESVLHVLNRSDVNILWRDNQSGCKGVCDGLPFENLSSAGHPTLCHGERCLDEILLEGLAEKITTSRSDMLIVLHMLGNHGPAYFQRYPASYRRWSPTCDTTDLASCSHEALVNTYDNAVLYTDHVLARTIDLLSGIRSHDTALLYVSDHGESLGEKGLYLHGIPYVIAPDEQIKVPMIWWQSSQVYADQACMQTHASRAPVSHDHLFHTLLGMFDVKTAAYTPELDLLATCRKGQPQ	10.79	gnl|BL_ORD_ID|4813|hsp_num:0	5886			1110	1197	colistin A; colistin B
BGC0000769.1|Glycopeptidolipid_23 # 16862 # 17200 # -1 # ID=1_23;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.658	BGC0000769.1|Glycopeptidolipid_23 	16862	17200	-	Loose	500	27.335	RSA-1	40.91	3004444	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	RSA beta-lactamase	TTGGGATCGGTAGCCGCCGGCCGGGCTTGTACTGGCGCAGCGACGGCGCCAATCCGGCGCCGCCCCACCGAAAGGAAGCCAGCAAGGAAGATCGTGCCCGCCAGCATCGAAGAACAGATCAACCGCGTGGATCGGCAGCGCAGCCTCTACATCGGGCTCGGCGCCGGCGCCGTGGCGGCGTGGAGCGTCTTTCGGCTGTTCTGGCTTGTCTACCTCGGGATGACATTCGGCTGGCTGTTCGGCGCGATGGTCTTCCAGGTGGTGTTGTGGGGGGTGATCGGCGTGGTCGCCGGGATTGCGGCAATCGGGTTCCTGAGCCGCTACACCAAGGGGTCGTAA	MGSVAAGRACTGAATAPIRRRPTERKPARKIVPASIEEQINRVDRQRSLYIGLGAGAVAAWSVFRLFWLVYLGMTFGWLFGAMVFQVVLWGVIGVVAGIAAIGFLSRYTKGS	MGMQLARSTILTVLLCLPIAVTATTKEEIQKIERQRNLTVGIALVDDGGTLLFGHRETQRFAMCSTFKLPLAAATLKQIESGKWSAAERLSYSAGQLDAYAPAAKRYLPTGYITVAEANQASVQLSDNTAANLLLDKLGGPSQLTSMFRSLGDSVSRLDRREPDLNTNVSGDPRDTTTPGAMARIVAKLVYGNYLSTAGREQLQRLLIGNNTGDSRIRAGIASGWTTGDKTGSCPNGGRNDAAFLVSPDGRRFALTVYLNAPSLDDKARNEVVATVARLAVESIR	39.30	gnl|BL_ORD_ID|2493|hsp_num:0	2884			60	126	
BGC0000769.1|Glycopeptidolipid_24 # 17255 # 17926 # 1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.746	BGC0000769.1|Glycopeptidolipid_24 	17255	17926	+	Loose	2000	27.7202	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	33.93	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGAACGTGTCGCGAGTTGCCCTGGTCCCCATCGCCGTCCTGGCCTGGGCGCTGTTCCTGCCGGCGGGATCCGCGGCGGCCGATCCGCCAGCCACCCAGGTGATCACCGTCGTGGCGGTCGGGCCGGACGGCCAAGCCATCAACGGCTATCGGGTGGCGTCCGGGCCCGACAGCGTCGGGCACGCATCCGAGTGTTCGCAACCGTCACCGTCGGCGGTCGACGACAACGTCTACTACTGTTCGCCGAGCGCCGCCGGCGCCGGCACCTGCTGGCCGTCCACGCCGGGATCCCTTCTGTGCGTAGACAATCCGTGGGACAGGCAGATGCACCGGGTGACGTTCGACGGGCAGCTGGCACCCGTGCGCGCGCCCGCCGACCCGGACCCGTTCGCGCTGACCCTCGACGACGGCACCCGCTGCCTGCTGCGCAACGGCGGCGCGTGGGGCGGGCGGGCCGACGGGTACGTCGGCGTCTACGGATGCGGCGGCGCCGGTTCGGATCTGGCCGTGCTGTGGCAGCCCAGCCAGGGCCGCGGCTCCTGCATCGACCGCTCGGCACCGGCGTGGACCGTCAAGGTCGGCCGGCTCGGGGCGCCGGACGCCGTGCTGCCGCCGCCGGCGACCCGGACGGTGACCGCCGCCTGGCTGGCCGGCGGCAGGGCCGGTCAGTAG	MNVSRVALVPIAVLAWALFLPAGSAAADPPATQVITVVAVGPDGQAINGYRVASGPDSVGHASECSQPSPSAVDDNVYYCSPSAAGAGTCWPSTPGSLLCVDNPWDRQMHRVTFDGQLAPVRAPADPDPFALTLDDGTRCLLRNGGAWGGRADGYVGVYGCGGAGSDLAVLWQPSQGRGSCIDRSAPAWTVKVGRLGAPDAVLPPPATRTVTAAWLAGGRAGQ	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	18.80	gnl|BL_ORD_ID|4719|hsp_num:0	2914			2835	3000	rifampin
BGC0000769.1|Glycopeptidolipid_25 # 17943 # 18152 # -1 # ID=1_25;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.595	BGC0000769.1|Glycopeptidolipid_25 	17943	18152	-	Loose	500	24.6386	ANT(3'')-Ib	48.15	3005062	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	GTGGTCGTGGAGCTTCGACCATTGGGTGATGATCTCGCGTTGGCGCTCCACACTGGTCGACTCATCTGTGGATACCGACAGCCGGACCCGGGCAAGAAACCGCATCTGAGCAGCATAGATCGTGTTCGGAAAAACCGCAACGCCGTCCAGCGCGCCGTGTCGGAAACATGGGTGATGGTGTGCCCTGGGCCTGACATACGTGCGTTATAG	MVVELRPLGDDLALALHTGRLICGYRQPDPGKKPHLSSIDRVRKNRNAVQRAVSETWVMVCPGPDIRAL	MPPPANEPVPAEVQPILDVVVRALGDDIAGAYLFGSAIAGGLRPDSDVDLLVLTHRTMSRQSREDLVAALMEVSGARAGRGPARNAEVTVVVLGDIAPWRHPARSDFVYGEWLRDDFAAGVVPAPTADPDLTLVLATALQSHRALMGPGLAEFLPAIPYADIRRAMADSLPGLVANVRGDERNVMLTLARMWVTVATGDIVPKDAAADWLLPRLPPERRALLATARDAYRGHVADEAWHECRADVSEWVSEVSQAIARTLHDSVKA	25.94	gnl|BL_ORD_ID|2787|hsp_num:0	3802			54	135	spectinomycin; streptomycin
BGC0000769.1|Glycopeptidolipid_26 # 18159 # 19466 # 1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.638	BGC0000769.1|Glycopeptidolipid_26 	18159	19466	+	Loose	700	30.8018	vanS gene in vanC cluster	27.54	3002933	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GTGGGGTGGGCCGAGGACATCGACGTATCGGGCAAGTTGTCCCCGTTCGACACGCCACAGTTCGGCGACTGGCTCAACAACCGCTACCCGGAATTCGATGGGGTAGTGGCCTGGAAGCTCGACCGGCTGGCCCGCAACATGTTCGGGCTCAATGACCTCTTCCAGTGGGCCAAGGCCAACAACAAGACGGTCGTCTCCATCACGGAATCGCTGGACCTGTCGACCACTGTCGGGGTGATGGTCGCGCAGATCCTTGCCGGGGTGGCGCAGATGGAGCTGGAAGCCATACAGGCCAGGCAGTCAGGATCGCAGGCCCATCTACGTCAAGTGGGGCGCTGGCCGGGTGGGAATGCACCCTACGGCTACCGGGTGGTGCGGAACGGCAACGGTTGCAAGCTTGACCTCGACCCCGAGAAGGCTGCCGTGGTGAGCATGATCGTGGACCGGATACTCGACGGCAACACGATGGCGTCCGTTTGCCGCGAACTGAATTCGGCCGGCGTCCCAGCCCCGAAGGGCGGCAAGTGGCAGATCAGCACAATGCGCCACCTGTTGCGCTCGCCAGCATTGCGCGGGCATCGAGTACACAAGGGCCAGGTGATCCTGGGGGATGATGGGCAGCCCGTCGCGTTCGGCCCCGAGCTGGTCGATGCTGAAACCTTCCAGCGGCTGCAGGCCGCGCTAGTTCCGGGCAACGGTGCGGGCGGTCGCAAGAATGCCTCGCCGCTATCAGGGCTGGCGAAGTGCGCCGAATGTGGGGCCGCAATGGGTTACGAGTCCAGCACTGGCCGCGACCACCGCCGCCGCTACTACTACCGCGCCAAGTGCGACCACCGGACGGCCATGCGAGCCGACCAGTTGGAGCAGATGGCCGAATCAATGCTGTTGTGGCACTACGGCGACAAGGAGATAACGCGTCGGGAGTGGATACCGGGCGAGGATCACACAATCGCGCTCCAAGAGGCCGTAGCCCGTTATGACGCATTGTCAGCACGGCTGACGGCGAACCTGCCCGAGATAGCTAAGCAGCGCCTGGAGAAGCAGCTAGAGGCCGTTGAGGCCGAGTTGGGCAGGCTCAGCGAACTGCCACAGGTGGAGGGACATTGGGCGCAGGTGGGCACGGGCCGAACTTGGAATATGGAATGGCTGGACGCTGACGTTGACCAGCGGCGCGCAATGCTGCGGGAGGCCGGTATGTCTTTCCTGGTCGCACCGAAGGGCGCTCGGGTCACGCTGGCAGTAAATGGATTACCGCAAATTGACCGTACAGAAGCGGCACGCCGTTTCGCCGGGCATCCGGTGATGTGA	MGWAEDIDVSGKLSPFDTPQFGDWLNNRYPEFDGVVAWKLDRLARNMFGLNDLFQWAKANNKTVVSITESLDLSTTVGVMVAQILAGVAQMELEAIQARQSGSQAHLRQVGRWPGGNAPYGYRVVRNGNGCKLDLDPEKAAVVSMIVDRILDGNTMASVCRELNSAGVPAPKGGKWQISTMRHLLRSPALRGHRVHKGQVILGDDGQPVAFGPELVDAETFQRLQAALVPGNGAGGRKNASPLSGLAKCAECGAAMGYESSTGRDHRRRYYYRAKCDHRTAMRADQLEQMAESMLLWHYGDKEITRREWIPGEDHTIALQEAVARYDALSARLTANLPEIAKQRLEKQLEAVEAELGRLSELPQVEGHWAQVGTGRTWNMEWLDADVDQRRAMLREAGMSFLVAPKGARVTLAVNGLPQIDRTEAARRFAGHPVM	MKNRNPLIRKLLTQYFVTTGILLAFLVMIPLVIRFIAGTRTWYGTEPIYYILRFFADRWLFCVAIGALLIWFGTTIYYMTKAIGYLNETIQATTQLIEEPSKRITLSSHLIDVQEEMNQLREKSLQDQRAAKEAEQRKNDLIVYLAHDLRTPLTSVIGYLTLLKEEPQLSNAMRNRYTEIALQKAQRLELLISEFFEITRFNLTTIVLQTETTDLSLMLEQLTFEFLPLLEEKNLNWQLNLQKNVLATVDTEKIARVFDNLIRNAINYSYPDSPLLLELVESDSIHIRLTNRGKTIPEEMIGRLFEPFYRMDSSRATATSGTGLGLPIAKEILLASGGDISAESKDETIIFNVRLPKPANN	120.50	gnl|BL_ORD_ID|904|hsp_num:0	966			492	681	vancomycin
BGC0000769.1|Glycopeptidolipid_27 # 19463 # 19720 # 1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.612	BGC0000769.1|Glycopeptidolipid_27 	19463	19720	+	Loose	375	25.409	ALI-2	38.1	3006895	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ALI beta-lactamase	GTGACTGGCATTTTGGGAGGCGCGATGTGTAGACCAACGCTGTGCTGGAACGCGGACAACGTGGCCATGCTGATGGAGTTCAGGGACATCCGCAACAGGGCAGCGCTGGCCAAAGCGATCAATTGGCCGCGCACCACGGTCTACAGATCGTTTAATGAGGACTGGTCGGGCCGGGTGCGCATGGAGGTGCTCGTGGCGATGTCGGTGACGTTCGACGTGCCCATCGGCTGGCTGGTTCTCGATCCGCAGGAGCGATGA	MTGILGGAMCRPTLCWNADNVAMLMEFRDIRNRAALAKAINWPRTTVYRSFNEDWSGRVRMEVLVAMSVTFDVPIGWLVLDPQER	MFKFITGIVVAFVSFNTLSAPMLKPLQFEEVTTNIFLVKSFREFKNLKSPDNPIIIDANSLIYIDSKDAYLIDTPWNAENMPQLMTWIENRDLTLKKTVFTHFHEDQTGGLEYLQEHGFDTYATKLTNTLLVKDNKKAANHELDAQESVLLDNKIEVFYPGPGHSKDNSVVWFPKEKVLLGGCLMRANEVNTIGWTGDADLAKWAQSAKNVLIKYPETKLVIPGHGDIGKGTSVISHTVNIAESL	34.69	gnl|BL_ORD_ID|3292|hsp_num:0	4361			225	327	
BGC0000769.1|Glycopeptidolipid_29 # 20258 # 20353 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.552	BGC0000769.1|Glycopeptidolipid_29 	20258	20353	+	Loose	2000	21.1718	Staphylococcus aureus mupB conferring resistance to mupirocin	29.03	3000510	protein homolog model	n/a	n/a	mupirocin-like antibiotic	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGCTGCGTTATCGGTCTACTGTCCCGAATACCGTTCACAGCAAGCGCGAGACGATGCGTTTATTGCCGCTCTCACCGCCCACGGTTGGCATTTGA	MLRYRSTVPNTVHSKRETMRLLPLSPPTVGI	MENENIIEEQKILNFWKEENIFKKSIDNRKNDNPFVFYDGPPTANGLPHTGHVLGRVIKDLFARYKTMQGFYVERKAGWDTHGLPVELGVEKKLGIKDKNEIEKYGIEKFINECKNSVFMYEKQWREFSELIGYWVDMEKPYKTMDNTYIESIWYILSDFHKKGLLYKGHKVTPYCPSCETSLSSHEVAQGYKEVKDISVILKFPILDSDENFLVWTTTPWSLPGNIALAINAEEIYVKVNYDNEIFIIMESLLQSVFKDEDNIDIVSKHKGKEFVGKEYLAPFPNKSLMNNENSYKVLPADFVTNKDGTGIVHIAPAYGEDDYKLVQENNIPFINVIDSRGKYNQDSPIFKGELAKESDINIIKELTHLNLLFKKEKYEHSYPFCWRCDNPLIYYAMEGWFIKTTAYKNEIKENNQKIEWYPDHIKNGRFGNFLDNMIDWNIGRKRYWGTPLNIWKCSTCSHEFSPKSINDLIQHSIEDIPSDIELHRPYIDNVKCKCQNCGGDMCREEEVIDVWFDSGSMPFAQNHYPFSGPIQNSYPADFIAEGVDQTRGWFYSLLVISTIFKGEAPYKNALSLGHILDSNGQKMSKSKGNVIDPISMIKTYGADSLRWTLVSDSVPWTNKRFSENMVAQSKSRVIDTLKNIFNFYNMYQKIDNYDYTRDTPKQLNLLDNWAISRMNSVIKEVELHLEKYNPTNASRAIGEFINEISNWYIRRSRSRFWSSEMNEDKKSAYFTLRLILINTCKIIAPFTPFTSEEIHLNLTKKSVHLEDFPQAKEEYINLKLEEDMNKVLDIVEKSRSIRNNINIKTKQPLSNMYIYDNNNLDNEFLRKYKDIIKDEINVKKINIVSDLDNFLEYDVKPNFSTLGPKLGKDMKQFQILFKNIKKEEMNKLINDFDKLQKVFDSLGVTIEEKDFIISKIPKKGFSLSSNDSDRLIILDTNLTQELIREGFVRELIRVIQQLRKQQNFNIEERINVVIDIDSDGLLSIKNNINILKENVLINNLKFEKRETMKYFKINQKEIGIQLMSSFTN	3.00	gnl|BL_ORD_ID|4698|hsp_num:0	2271			2982	3075	mupirocin
BGC0000769.1|Glycopeptidolipid_30 # 20350 # 20544 # 1 # ID=1_30;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.544	BGC0000769.1|Glycopeptidolipid_30 	20350	20544	+	Loose	500	23.0978	mphC	39.29	3000319	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	TTGAAGGATGGCCCCGACAAATTCCGCCTGGTGGTTAACGCTGGCCGTGAAGTTTGCAAGATGATGGATCAAGGAAAGAGCCGGGGCGAGATGGTGGATGAGGTCTACAACGTTCACACTGAAGGTGAGACGAGGCCTCTCGCCGAGAATTTCGTGGCCGCGGCGATCAGGTATTATTGTCCGCAGTTCCAATGA	MKDGPDKFRLVVNAGREVCKMMDQGKSRGEMVDEVYNVHTEGETRPLAENFVAAAIRYYCPQFQ	MTRHNEIIKCAEKYQLHIQPQTISLNESGLDFQVAFGKDKHGVEWVLRLPRRPDVYKRTKPEKQTVDFLQKNVSFEVPKWKVHERDLIAYPKLTGKPAATIDPEIQNYVWEIEHKPLPENFINTLAETLVDLHNIPEENINVQHINIKTIQEIKNDFQRRMNKVKETYGVSDELWNRWKQWLENDELWPRHATMIHGDLHPGHIMVDNQANVTGLIDWTEATHSDPSMDFMGHHRVFDDEGLEQLITAYGKAGGEIWPRMKEHIIELNAVFPMFIAEFAMESGESAYETMALKELGMKE	21.40	gnl|BL_ORD_ID|1899|hsp_num:0	2062			282	366	erythromycin; roxithromycin; telithromycin; clarithromycin; tylosin; spiramycin; azithromycin; dirithromycin; oleandomycin
BGC0000769.1|Glycopeptidolipid_31 # 20926 # 21093 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.571	BGC0000769.1|Glycopeptidolipid_31 	20926	21093	+	Loose	500	21.1718	GOB-36	77.78	3005685	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	GOB beta-lactamase	ATGCATTCACCAGCCCCCGGCCGTGACGTCGAAAAAAGGCCAGAAAGAAAACCTTACGTCACAGCCAGCCGCAATCGGGGGAAAGCAGAAGAAAACCCCATTGCGGCGTATTGGAGGGGGAATGGGCGCTGGTTCCCGCACGGAATTGAAAACCCATCCCCCCTGTAG	MHSPAPGRDVEKRPERKPYVTASRNRGKAEENPIAAYWRGNGRWFPHGIENPSPL	MKRITTLLFLLVCFGWNAQTVKEPENTPKEWSQNYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGLAGSLSTIKENIAKLEFNYKDIKILLLTQAHYDHTGALMDFKTETGAKFYADAADADVLRTGGQSDYEMGKYGATFKPIIPDRTLKNLDKIKLGNTTLTMLHHPGHTKGSCSFVFDTNDGKRKYRVLIANMPSIIIDNKFSEVTAYPNIQSDYAYTFNAMKKLDFDIWVASHASQFDLHEKRKEREPYNPQLFMDKQNYFQSLNNLEKSYLDKIKKDSQDK	18.97	gnl|BL_ORD_ID|3580|hsp_num:0	4649			744	771	
BGC0000769.1|Glycopeptidolipid_32 # 21319 # 22545 # -1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.612	BGC0000769.1|Glycopeptidolipid_32 	21319	22545	-	Loose	750	30.8018	smeD	50.0	3003055	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAATTGAACACAAAAGAATATCAGGCCCTCAAGGCCCAGTTGAGATCGGTCATTCGAGAATCCCTCAACAAAGGCAATTCAAACGCCGATGAGGGAAACCTAGATTCGGCCGCAATTAATGCCCTCGCCATGTACGGCGGCGACTCAGGCTCGATGCCCACACCACCGGCAGACACCCAGCTCTTCAACGGCCTGGTGGACTGCAGGACCATCACCCACACGGGCGGACAACTCGCACCGCTGACCTTTGACGGCAAGGCGCTCAGCGCAATTGGTACCTCGTATGAGACCAACGCGCCCATTCGGGTGAAGGCCTTCAACGCGGAAACCAAGACCCCCACCCCGTCGCTGCCGTCCATGACCGGACTTCTGCCCGCGCAGCTTCACCCCAATGTGGTTGAGAGAGTGTGGGATATACGCGTTGCTGACCTGCTGCCTGCCATCACCGCGGATTCCTCGTCCTACGAATTCCTGAAGGACACAACCACTTCCGCAGCACAGGCCGCGGTGGTCGGTGAGGGCCAGGTTAAGCCCCAGGTTGACATCACCCTGACCCCTGAGACGTTCAGCTTCGCCAAGATCGCCGGATTGCTCAAGCTCTCCCGTGAGCAGGTCGCGGACTTCAGTCAGGCCCTCGGGTATTCGATCAACCAACTGCAGCGCAACATCATCTCCGCGGAGAACCACCAGTTGCTGTACGGGGATGGGTCGACCAACAGCGATGGGTCGATCAACATGACCGGGCTGGCCCACACCAGCGGCATCCTGACACACACGGCCGGCACCCTGTCGGGCACAGAGAGCCACCTGGACTCGATCCTGGCCGCTATCGACGCCATGCGCAGCGGCCCCGCCCTGGCCTCGCCGTCGTTCGCCCTCGTGCATCCGACAACGTGGCACTCTGTATGCCTGGAAAAGGACGGACTGAACCGCAGTTTGGTGTCACCCGACCCAACCAAGGACAGCGCCCTTCAGGTCTGGGATGTCCCGGTCAAACTGTCCACCGACGTCGCCAAGGGTGACCTGTTCCTGGTGGACACGACCAAGATGGGCTACTTGGTCATCCGCGAGGGCCTGCAGATCTTCGGCCCCGCCCACGATCAGGACGACTTCAGCCGCAACCTGACCTCCTGGGTGGCAGAGCTTCGCGAAAACCTCGCAGTCGTCAGGGCTTCCGCGGTCTACCTGCTGCAGGGCCTGCCGACCAGCATCACGGCGCCGTGA	MKLNTKEYQALKAQLRSVIRESLNKGNSNADEGNLDSAAINALAMYGGDSGSMPTPPADTQLFNGLVDCRTITHTGGQLAPLTFDGKALSAIGTSYETNAPIRVKAFNAETKTPTPSLPSMTGLLPAQLHPNVVERVWDIRVADLLPAITADSSSYEFLKDTTTSAAQAAVVGEGQVKPQVDITLTPETFSFAKIAGLLKLSREQVADFSQALGYSINQLQRNIISAENHQLLYGDGSTNSDGSINMTGLAHTSGILTHTAGTLSGTESHLDSILAAIDAMRSGPALASPSFALVHPTTWHSVCLEKDGLNRSLVSPDPTKDSALQVWDVPVKLSTDVAKGDLFLVDTTKMGYLVIREGLQIFGPAHDQDDFSRNLTSWVAELRENLAVVRASAVYLLQGLPTSITAP	MLLSRIRPFALSLAIAATVAACGGQPQAPEQGPGDVTVVTLKSETVGLTRELPGRTNAFLVAEVRPQVNGIVAKRLFTEGGMVKAGEPLYQLDDASYRAQANNARAQLARAEATANAARLSAKRITELAKVDAVSQQDLENAVAAQKQAEADVGAAKASLDAANVTLGYARITAPISGRIGKSSVTQGALVSAGQANALATVQQLDPIYVDLTQSSAELLQLRRELAAGRLQDNQTLPVSILMEDGSTFEHKGTLEFSEVSVDPTTGSFGLRVKVDNPDGLLMPGMYVRAVIGGGVRSDAVLVPMQGIARDPKGDTTAMVVGKDNKVEVRPVKVSRTVGDKWLVEDGLKAGDKVIVEGLQKIGPGMPVKATEKGDAPAKPAAAAQPAAPAGDAK	103.55	gnl|BL_ORD_ID|255|hsp_num:0	284			966	1092	tetracycline; chloramphenicol
BGC0000769.1|Glycopeptidolipid_33 # 22849 # 23412 # -1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.633	BGC0000769.1|Glycopeptidolipid_33 	22849	23412	-	Loose	400	27.7202	Limosilactobacillus reuteri cat-TC	23.29	3002671	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGACATTTGCGACCCAGGTCGCCGCGACCTTTGCCCCTATCCAGGCGGTCTACGACGACGTAGCCCAGGCCCTGAGCTGGGCACAGTCCTTCGTGGAGAACTACTGCAACCGCACCTTCGACCTGGTTACCGATGATGTCGCCGTTGTCGACCCCCACCCGCATCGACGGGCACTGCTACCGATGATTCCGGTAGCCGACGTGTCCAGCGTCGAGGCCCTGATCTGCGGGGCCTGGACCGCCTTGACCAACTACGCCTACGTCGGTGAGACCGGGCTGCTCTATGACACCACCGGGGAGCCGGGTACCACCTCGGACGCGTGGCCCTGGCTGCCGGGAAGCCTGAGAGTGACCTACACCCACGGCTACACCGACGTGCCCCAGGACCTGATTAACACCGCCTGCCGCTTCGCCCAGCAGTACCTAGAGAACCCCACTCTGCTGCTACAGCGCGAGGTGGGCTCATTCAGCGAACGCTACGCCGGCAACACCGGTGGGGTGGGCATCGTGATCAACGAGTTCGACAAGCGAATAATGGACCGCTACACCCTGATGACCACATAG	MTFATQVAATFAPIQAVYDDVAQALSWAQSFVENYCNRTFDLVTDDVAVVDPHPHRRALLPMIPVADVSSVEALICGAWTALTNYAYVGETGLLYDTTGEPGTTSDAWPWLPGSLRVTYTHGYTDVPQDLINTACRFAQQYLENPTLLLQREVGSFSERYAGNTGGVGIVINEFDKRIMDRYTLMTT	MNFNKIDLDNWKRKEIFNHYLNQQTTFSITTEIDISVLYRNIKQEGYKFYPAFIFLVTRVINSNTAFRTGYNSDGELGYWDKLEPLYTIFDGVSKTFSGIWTSVKNDFKEFYDLYLSDVEKYNGSGKLFPKTPIPENAFSLSIIPWTSFTGFNLNINNNSNYLLPIITAGKFINKGNSIYLPLSLQVHHSVCDGYHAGLFMNSIRNCQIGLMTGFYNIDKPTVLFTVGFLMSLTCPLI	78.57	gnl|BL_ORD_ID|4666|hsp_num:0	1524			252	456	azidamfenicol; chloramphenicol; thiamphenicol
BGC0000769.1|Glycopeptidolipid_34 # 23442 # 24035 # -1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.613	BGC0000769.1|Glycopeptidolipid_34 	23442	24035	-	Loose	810	26.5646	cdeA	26.32	3003835	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGGGACGGAGCTGTCCGGTACAGACGATCTATCGACCCCCGGCGCGAGCAAGCATTCCTATCGCTTACGACGCCCTCAACAGCGGCGCGTCACATACCGGGACCGCGGGCGCAACGCCCATCCTCGCAATCGGCACCCAAGGGGGCTCAAATGTTGCCGCCACCTACGGCGGTGTCGCAATGGCGCCCCTGGCCAGTGTCACCGGGTCTACCTATCTCTTCGGCCTGCTAGGTGCCTGCACCGGAACAGCGCAGAGTATCGCCATTACCGGCTCGTGGAACCGTATCTATTACGCGTGCGCATCGTTCAAGCACGTTAGGTCGTTCGGCACGCCGGTGACCAACAGCAGTACCGGCACGCTAGCCGTTCCCAGCGCGCCAAGTCAGTTCGTGGTCAACGCATTCAGTAACGCCGGCAACAACGGAAACAGCTACGGCGGATACAACCAGACCATATTGAGCAGCCAGGCATCGGGATTCACCGCGAACTTCCTATCCTTCATCATGGGCTATGCCGCGGCCGGCTCCCCTGGGCTGACGTTCACGGTCAACTACGCATCGTCTCAAGCCGTGGCGGTCCCGCTGAATCCGTAA	MGRSCPVQTIYRPPARASIPIAYDALNSGASHTGTAGATPILAIGTQGGSNVAATYGGVAMAPLASVTGSTYLFGLLGACTGTAQSIAITGSWNRIYYACASFKHVRSFGTPVTNSSTGTLAVPSAPSQFVVNAFSNAGNNGNSYGGYNQTILSSQASGFTANFLSFIMGYAAAGSPGLTFTVNYASSQAVAVPLNP	MENLFTRKFTTFEFLKFVSPAIISMIFISLYTIIDGIFVSTLVGSDALASINIVLPIINLVCGFGIMMATGGGAIVSIRMGENRQDEANSTFSFIVLFSLIVGILFTVISYFFIKEISILLGATDKLLPYCITYGKVMILCTPFYILKFIFEYFARTDGNSKFSLFLSVIGGVTNIILDYVFIKYFGMGLLGAAVATAIGIILTCVLGIIYFLSNKSTLKLRKPKTDFRLIRDTMINGSSEMVTELSTGITTFLFNVVALKLAGENGLAALTIVLYAHFLMTSVYLGFAAGVSPLISYNFGAENSDKLKETFKHSLKFIFISSLLVFIIALVFAPFIVRVFVNPDNTVFKLALQGLKIFAFAFLFVGINIFASGFFTAFHNGKISAIISFSRAFVFIIIGIIILPPMLNMTGLWLTVPFAEVITIFISILFIKKYKGRYKY	44.67	gnl|BL_ORD_ID|2083|hsp_num:0	2321			474	894	acriflavine
BGC0000769.1|Glycopeptidolipid_35 # 24180 # 24428 # 1 # ID=1_35;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.566	BGC0000769.1|Glycopeptidolipid_35 	24180	24428	+	Loose	175	24.2534	vanTm gene in vanL cluster	48.15	3002973	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	GTGAACACCCTGAGCAGGGAATCTAGGTGCGCCATCTCCGCCTCACCTGCGCGTTTACATCCCTCGCAGCACCAGCGAGAAGGCCTGCCGCCATTCGGATTTCGCGTTATAGGCGTATCGCACTTCGGGCAGGTAGCAGGGTGGTACCTGGTCAATGAATCTCCTTCATTTGCAACGCATTTCGTCTGTCGCGTGGTGATGGACGATGCGTGCGAAAGCTATTGCGCTAGAGCGCATTCCGAGCTATAG	MNTLSRESRCAISASPARLHPSQHQREGLPPFGFRVIGVSHFGQVAGWYLVNESPSFATHFVCRVVMDDACESYCARAHSEL	MKKQNTGVNNFRLIAAAMVVAIHCFPFQTISKELDTLVTLTVFRIAVPFFFMVSGYYLLGPIPSSATNTYQINNYIKKQLKVYTFAIVLYLPLAFYSQSITLDMSIISFIKQLLFNGFFYHLWFFPAWVLGLLIVQFLLKRMNIQTVLFITFVAYLIGLGGDSWWGIVKQVPFFFRFYNAIFQLFGYTRNGLFYAPLFFALGAYLYKMNIKNFNSARNNYLLLLFSIEMILESYFLHLFNIPKHDSMYLFLPFVMTLVFIKIYNWSPKNNLLNSSQLSLGVYLIHPYIIAVIHSISIYVSIFTNSIINYLSVLLISYLTIRLILKRKEW	24.92	gnl|BL_ORD_ID|4729|hsp_num:0	229			126	204	vancomycin
BGC0000769.1|Glycopeptidolipid_36 # 24385 # 24582 # 1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.586	BGC0000769.1|Glycopeptidolipid_36 	24385	24582	+	Loose	500	26.5646	PNGM-1	35.71	3004571	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	PNGM beta-lactamase	ATGCGTGCGAAAGCTATTGCGCTAGAGCGCATTCCGAGCTATAGTCGCGGTATGCACACCGTTGCAGCGACAGGGTTCCGATTCCGCCCGTGGTGCTGCATTTCCGCAGGTCAGAGCCCGTTTTTGAGGTTTCTGAAACCCCTTGGGGCACCGGCAATTTGGCACGCGCAGGACATAGCCCGAAGGGTCGCACGGTAA	MRAKAIALERIPSYSRGMHTVAATGFRFRPWCCISAGQSPFLRFLKPLGAPAIWHAQDIARRVAR	MAGGKVTSSTGIAPKRYVYYPGSEELGPDEIRVIACGTGMPTARRAQAAAAWVVELGNGDKFIVDIGSGSMANIQSLMIPANYLTKIFLTHLHTDHWGDLVSMWAGGWTAGRTDPLEVWGPSGSREDMGTKYAVEHMLKAYNWDYMTRAVTINPRPGDINVHEFDYRALNEVVYQENGVTFRSWPCIHAGDGPVSFALEWNGYKVVFGGDTAPNIWYPEYAKGADLAIHECWMTSDQMMTKYNQPAQLALRINLDFHTSAQSFGQIMNMVQPRHAVAYHFFNDDDTRYDIYTGVRENYAGPLSMATDMMVWNITRDAVTERMAVSPDHAWDVAGPSEDLAPDRNRASEYTQYILDGRLNVDEANAHWKQEFMGRTGLTTEDLGVGS	16.84	gnl|BL_ORD_ID|2715|hsp_num:0	3272			531	657	
BGC0000769.1|Glycopeptidolipid_38 # 24846 # 24971 # -1 # ID=1_38;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.603	BGC0000769.1|Glycopeptidolipid_38 	24846	24971	-	Loose	300	22.7126	ANT(2'')-Ia	57.14	3000230	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(2'')	ATGAACCGTTCGAGTTCGAACGATTTGCCCCTATGCATCGGGGGAGGCTGGACTAAGCGTCGGGCAGAACCCCCGATCCAGTCCATGGTTGGCCCGTTCGATATTGAGCAGGCCCAGCGCGGATGA	MNRSSSNDLPLCIGGGWTKRRAEPPIQSMVGPFDIEQAQRG	MDTTQVTLIHKILAAADERNLPLWIGGGWAIDARLGRVTRKHDDIDLTFPGERRGELEAIVEMLGGRVMEELDYGFLAEIGDELLDCEPAWWADEAYEIAEAPQGSCPEAAEGVIAGRPVRCNSWEAIIWDYFYYADEVPPVDWPTKHIESYRLACTSLGAEKVEVLRAAFRSRYAA	23.16	gnl|BL_ORD_ID|1258|hsp_num:0	1372			45	87	dibekacin; sisomicin; kanamycin A; tobramycin; gentamicin
BGC0000769.1|Glycopeptidolipid_39 # 24968 # 25246 # -1 # ID=1_39;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.631	BGC0000769.1|Glycopeptidolipid_39 	24968	25246	-	Loose	600	23.0978	APH(9)-Ia	27.91	3002662	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(9)	ATGCCACTATCGCGCGGGCTATTCCGTGCTGATCGTGACGGCACGAGAAGAACGTTGGCGCCACCACACCCTTGGACTGGCTGGCCACCCACCAGGTACCCCACCAATGGGCTATGGATGCGCAGAAACGGGGACACCCGGCCGGATCACCACATCAAGGCCGAGATCTTCCACGAGCTGGCACACCACTACCTCATCCGCGCGGCCATTGACGACCACCCCGACGTTCTGGACACCTGGAAACGCCTGGGCATCCCCAGCGTCGTGGGGATGGGATGA	MPLSRGLFRADRDGTRRTLAPPHPWTGWPPTRYPTNGLWMRRNGDTRPDHHIKAEIFHELAHHYLIRAAIDDHPDVLDTWKRLGIPSVVGMG	MLKQPIQAQQLIELLKVHYGIDIHTAQFIQGGADTNAFAYQADSESKSYFIKLKYGYHDEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNGFTQNLTGKQWKQLGKVLRQIHETSVPISIQQQLRKEIYSPKWREIVRSFYNQIEFDNSDDKLTAAFKSFFNQNSAAIHRLVDTSEKLSKKIQPDLDKYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPKERDLMFIGGGVGNVWNKPHEIQYFYEGYGEINVDKTILSYYRHERIVEDIAVYGQDLLSRNQNNQSRLESFKYFKEMFDPNNVVEIAFATEQ	27.79	gnl|BL_ORD_ID|227|hsp_num:0	252			237	366	spectinomycin
BGC0000769.1|Glycopeptidolipid_41 # 26105 # 26653 # -1 # ID=1_41;partial=00;start_type=ATG;rbs_motif=CCCCCC;rbs_spacer=5bp;gc_cont=0.590	BGC0000769.1|Glycopeptidolipid_41 	26105	26653	-	Loose	400	28.1054	vanR gene in vanI cluster	29.9	3003728	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGGACTGCTCCGCGTTCTTCTCGTTGATGCAACGTGGCGCCCACGATGAAATTCTCCGCGCGATCGAGCGCAACCCGGGAATTGTCTCTGATACGTGGGGACGCCCGTGGGGTGAGCACTGGGACCGCGAACGATGGCGGATATCCGGCGATGTGGGATGGGATGACCTCGCCTGGCCGTGGGCATTCTGGAAGGCCGGCTACACCGACAACCACCTCCCAGCGACGAAACCCACCGGCCCTATTCGGCTCTATCGCGGAGCACCACACGATCGCCGCTTCGGCATGGGCTGGACGACCAAGTACGACTACGCCCACAAATATGCGGTGTCCAACCTGATCGGTGTCAGCGGCCATGTGTATCTGCATTGGGCGTGGGGTGAGGAACTATTCGCCCACGTTCACAACGACACCCAGGATGAATACGTATTGGACACAAGGTATTTGAACGATCACAACGTGGCGAAGCTTCCGCTAGCACCGACTGAATACGCCGCGCTGTATACGAGATGCATTACCGCGCGTCCGGCTTTTAAGTACGGCGCATGA	MDCSAFFSLMQRGAHDEILRAIERNPGIVSDTWGRPWGEHWDRERWRISGDVGWDDLAWPWAFWKAGYTDNHLPATKPTGPIRLYRGAPHDRRFGMGWTTKYDYAHKYAVSNLIGVSGHVYLHWAWGEELFAHVHNDTQDEYVLDTRYLNDHNVAKLPLAPTEYAALYTRCITARPAFKYGA	MAANILIVDDEQAIADLVEVYLKNENYNLFKFYNGKDALDCIEKEKLDLAILDVMLPDVDGFSICRQIREKHNFPVIMLTAKEEEIDKITGLTLGADDYITKPFRPLELIARVKAQLRRFTKYNSAEPNQEEHVIAFSGLVLDMDTHECTLNEKKLSLTPTEFSILWVLCSNRGRVVSSEELFSEVWGDKYFTNSNNTVMVHIRHLREKMQDSAEHPKYIKTVWGVGYKIEK	78.45	gnl|BL_ORD_ID|2065|hsp_num:0	2246			300	510	vancomycin; teicoplanin
BGC0000769.1|Glycopeptidolipid_44 # 27204 # 27323 # 1 # ID=1_44;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.625	BGC0000769.1|Glycopeptidolipid_44 	27204	27323	+	Loose	1000	21.9422	tet(43)	40.0	3000573	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCTCGCCCCATTCCAATTCTTCAGCCTCACCGGGTTGCAGGTCGCGCAATTTCGGTTCGGCCGGCGCGTCGCTGTAGTGGTTGGGGATGGCGATTCCGTAGGCCCCGTGAGTAGGTGA	MLAPFQFFSLTGLQVAQFRFGRRVAVVVGDGDSVGPVSR	MPPSHHMLRPIEQCSILWNDVRYSNSVRLKEAGMTATTQASAPAARTYLSLRAAWIPLFALCLAFFVEMVDNTLLTIALPTIGRDLGASVTSLQWVTGAYSLTFGGLLLTAGSLADRFGRRRVLQIGLLAFGLISLTVIAVATAGQLIAVRAALGLAAAAMAPITNSLVFRLFEGEDLRRRAMTLMIVVGMSGFILGPLLGGTVLAHASWQWLLLINAPIALIALIGVRLGVPADDAEGLTKDRLDVKGSALSIAAIGLACYTLTSGVEHGWMSAVTWACGIGAAAALMGFVWHERRTDHPMLDLDVFRNRTVRGASIAQVGTSIAMASLMFGLILHFQGAYGWSPMRAGLANLPLILTMILATPVSEGLAKRFGHRIAMLIGAGLLAGSLAGLAWGVGHGYLVIAVFMVTFTLGLRTVMTIAAVGLVGAMPENRTSLGAALNDTAQEVGTSLGMAVIGTLIAVLXTTTLPNGDXSLDLATSYFAGERIAYLFLAVVVGVIAGWGALTLSNSKEMEDVH	7.51	gnl|BL_ORD_ID|1634|hsp_num:0	1773			1116	1176	tetracycline
BGC0000769.1|Glycopeptidolipid_45 # 27320 # 27514 # 1 # ID=1_45;partial=01;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.574	BGC0000769.1|Glycopeptidolipid_45 	27320	27514	+	Loose	800	22.3274	PDC-43	57.14	3005134	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	GTGAAGCTGGGGAACGTTGTCGGAGGATTCGAGCACCACAGGCAGATGCGGTTGCCAGTACCCCAATATGCGAGGTTGGGTTTCGGGGTCATCCATGTCTTGAGCACAGTGTGGTCGTACTCCATGAGGGGGTGGCCCTTATGGCAAGTCACCTGCGGCCGTTGGCGTTTGACCTTCTGCTCAGCTTCGACCAAT	MKLGNVVGGFEHHRQMRLPVPQYARLGFGVIHVLSTVWSYSMRGWPLWQVTCGRWRLTFCSASTN	MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPVPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR	16.37	gnl|BL_ORD_ID|2841|hsp_num:0	3860			954	996	
